08:00 , Mar 6, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Thyroid cancer Anaplastic lymphoma kinase (ALK); striatin calmodulin binding protein (STRN) In vitro and mouse studies identified STRN-ALK fusions in highly aggressive thyroid cancers that...